In particular, a lower ribose biosynthesis rate might mask folate deficiency or confer methotrexate resistance, with potentially broad implications in metabolic disorders and cancer therapy
In my opinion, patients should absolutely be asking more questions about this
While guidelines provide a framework, real-world decisions often depend on individual patient needs
Semaglutide has been used since 2017 for managing type 2 diabetes (under the brand name Ozempic) and more recently, since 2021, for weight loss (as Wegovy)
FDA Decision and Its Implications Details on the FDA Ruling Under current regulations, compounding pharmacies are permitted to produce medications that closely resemble brand-name drugs only in certain situations, including when there is an official shortage of those drugs
Probably but make sure your provider is aware of your history